129.18
price up icon2.32%   2.93
 
loading
Illumina Inc stock is traded at $129.18, with a volume of 1.16M. It is up +2.32% in the last 24 hours and up +7.90% over the past month. Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
See More
Previous Close:
$126.25
Open:
$126.31
24h Volume:
1.16M
Relative Volume:
0.53
Market Cap:
$20.58B
Revenue:
$4.43B
Net Income/Loss:
$-3.04B
P/E Ratio:
-4.8546
EPS:
-26.61
Net Cash Flow:
$357.00M
1W Performance:
+3.85%
1M Performance:
+7.90%
6M Performance:
-2.71%
1Y Performance:
-14.32%
1-Day Range:
Value
$126.31
$129.71
1-Week Range:
Value
$120.51
$129.71
52-Week Range:
Value
$89.00
$152.87

Illumina Inc Stock (ILMN) Company Profile

Name
Name
Illumina Inc
Name
Phone
(858) 202-4500
Name
Address
5200 ILLUMINA WAY, SAN DIEGO, CA
Name
Employee
9,300
Name
Twitter
@illumina
Name
Next Earnings Date
2024-08-06
Name
Latest SEC Filings
Name
ILMN's Discussions on Twitter

Illumina Inc Stock (ILMN) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-16-24 Downgrade HSBC Securities Buy → Hold
Jan-04-24 Downgrade TD Cowen Outperform → Market Perform
Dec-18-23 Upgrade Scotiabank Sector Perform → Sector Outperform
Dec-15-23 Upgrade Bernstein Underperform → Mkt Perform
Dec-14-23 Initiated Guggenheim Buy
Dec-14-23 Initiated Stephens Overweight
Dec-13-23 Initiated Wolfe Research Outperform
Dec-12-23 Downgrade BofA Securities Neutral → Underperform
Dec-11-23 Upgrade Citigroup Sell → Neutral
Nov-10-23 Downgrade Canaccord Genuity Buy → Hold
Sep-28-23 Initiated Bernstein Underperform
Jul-05-23 Resumed JP Morgan Neutral
Jan-25-23 Downgrade Argus Buy → Hold
Jan-05-23 Initiated Scotiabank Sector Perform
Dec-12-22 Downgrade Citigroup Neutral → Sell
Dec-07-22 Initiated RBC Capital Mkts Outperform
Oct-04-22 Upgrade SVB Leerink Mkt Perform → Outperform
Sep-28-22 Upgrade Evercore ISI In-line → Outperform
Aug-25-22 Initiated Credit Suisse Neutral
Jul-13-22 Downgrade Barclays Equal Weight → Underweight
Jan-18-22 Upgrade Stifel Hold → Buy
Jan-11-22 Upgrade Barclays Underweight → Equal Weight
Jan-07-22 Upgrade BofA Securities Underperform → Neutral
Jan-06-22 Resumed Morgan Stanley Equal-Weight
Jan-06-22 Resumed Piper Sandler Overweight
Oct-15-21 Resumed Cowen Outperform
Aug-19-21 Downgrade SVB Leerink Outperform → Mkt Perform
Jun-01-21 Upgrade Evercore ISI Underperform → In-line
Mar-31-21 Downgrade Atlantic Equities Overweight → Neutral
Mar-31-21 Upgrade Canaccord Genuity Hold → Buy
Mar-03-21 Initiated Barclays Underweight
Dec-22-20 Upgrade Piper Sandler Neutral → Overweight
Dec-17-20 Upgrade BTIG Research Neutral → Buy
Oct-13-20 Downgrade Guggenheim Buy → Neutral
Sep-30-20 Initiated Atlantic Equities Overweight
Sep-29-20 Downgrade Wolfe Research Outperform → Peer Perform
Sep-22-20 Downgrade Stifel Buy → Hold
Sep-22-20 Downgrade UBS Buy → Neutral
Sep-21-20 Upgrade Guggenheim Neutral → Buy
Sep-21-20 Downgrade JP Morgan Overweight → Neutral
Sep-09-20 Initiated Morgan Stanley Equal-Weight
Aug-07-20 Downgrade Evercore ISI In-line → Underperform
Aug-07-20 Downgrade Piper Sandler Overweight → Neutral
Jul-07-20 Downgrade Guggenheim Buy → Neutral
Apr-24-20 Downgrade Citigroup Buy → Neutral
Apr-21-20 Downgrade Robert W. Baird Outperform → Neutral
Jan-08-20 Initiated Wells Fargo Underweight
Jan-07-20 Initiated Citigroup Buy
Jan-02-20 Downgrade Evercore ISI Outperform → In-line
Nov-15-19 Initiated Stifel Buy
Oct-25-19 Initiated Guggenheim Buy
View All

Illumina Inc Stock (ILMN) Latest News

pulisher
07:32 AM

Wilkins Investment Counsel Inc. Boosts Stock Position in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat

07:32 AM
pulisher
Sep 14, 2024

Illumina, Inc. (NASDAQ:ILMN) Position Lifted by Federated Hermes Inc. - MarketBeat

Sep 14, 2024
pulisher
Sep 13, 2024

Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch

Sep 13, 2024
pulisher
Sep 13, 2024

Goldman Thinks Illumina, Inc. (ILMN) Is A Long-Term AI Stock Set To Rally Eventually - Yahoo Finance

Sep 13, 2024
pulisher
Sep 13, 2024

FULC Stock Falls as Muscle Disorder Study Misses Primary Goal - Benzinga

Sep 13, 2024
pulisher
Sep 13, 2024

Wedbush Securities Inc. Sells 916 Shares of Illumina, Inc. (NASDAQ:ILMN) - Defense World

Sep 13, 2024
pulisher
Sep 13, 2024

Los Angeles Capital Management LLC Has $843,000 Stock Holdings in Illumina, Inc. (NASDAQ:ILMN) - Defense World

Sep 13, 2024
pulisher
Sep 12, 2024

Liquid Biopsy Market to Reach $ 32.54 Billion, Globally, by 2033 at 11.61% CAGR: The Brainy Insights - GlobeNewswire Inc.

Sep 12, 2024
pulisher
Sep 12, 2024

Argus Research Upgrades Illumina (ILMN) - MSN

Sep 12, 2024
pulisher
Sep 12, 2024

Illumina Wins Court Fight With EU Over $7 Billion Grail Deal - MSN

Sep 12, 2024
pulisher
Sep 12, 2024

North America Protein Chip Market Latest Growth and Insights - openPR

Sep 12, 2024
pulisher
Sep 12, 2024

Headlands Technologies LLC Purchases 4,224 Shares of Illumina, Inc. (NASDAQ:ILMN) - MarketBeat

Sep 12, 2024
pulisher
Sep 12, 2024

TD Asset Management Inc Sells 29,166 Shares of Illumina, Inc. (NASDAQ:ILMN) - Defense World

Sep 12, 2024
pulisher
Sep 11, 2024

Illumina Inc. stock rises Wednesday, still underperforms market - MarketWatch

Sep 11, 2024
pulisher
Sep 11, 2024

Daiwa Securities Group Inc. Grows Position in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat

Sep 11, 2024
pulisher
Sep 11, 2024

In Edinburgh, taking comprehensive genomic profiling to the next level - Illumina

Sep 11, 2024
pulisher
Sep 11, 2024

EU Merger Control Concerns Remain After ECJ Illumina Ruling - Law360

Sep 11, 2024
pulisher
Sep 11, 2024

Bull of the Day: Illumina (ILMN) - MSN

Sep 11, 2024
pulisher
Sep 11, 2024

Microfluidic Market Growth and Future Outlook Industry - openPR

Sep 11, 2024
pulisher
Sep 11, 2024

Commission withdraws several decisions in the Illumina/GRAIL case - EU Reporter

Sep 11, 2024
pulisher
Sep 10, 2024

Vision Capital Management Inc. Sells 14,921 Shares of Illumina, Inc. (NASDAQ:ILMN) - MarketBeat

Sep 10, 2024
pulisher
Sep 10, 2024

Congress zeroes in on biotechs with connections to China. Here's one company's story - The Business Journals

Sep 10, 2024
pulisher
Sep 10, 2024

Illumina and Exxon Mobile have been highlighted as Zacks Bull and Bear of the Day - Yahoo Finance

Sep 10, 2024
pulisher
Sep 10, 2024

Bull Of The Day: Illumina (ILMN) - Barchart

Sep 10, 2024
pulisher
Sep 10, 2024

Bull of the Day: Illumina (ILMN) - Yahoo Finance

Sep 10, 2024
pulisher
Sep 10, 2024

Bull of the Day: Illumina (ILMN) - Zacks Investment Research

Sep 10, 2024
pulisher
Sep 10, 2024

DNA Sequencing Market Future Business Opportunities 2024-2031 | Thermo Fisher Scientific, Inc., Illumina, Inc - openPR

Sep 10, 2024
pulisher
Sep 09, 2024

For the first time ever, gene expression can be mapped from space - Illumina

Sep 09, 2024
pulisher
Sep 09, 2024

Illumina Strategically Manages Debt and Issues New Notes - TipRanks

Sep 09, 2024
pulisher
Sep 09, 2024

Rocket Stock Down More Than 30% in Past Six Months: Here's Why - Benzinga

Sep 09, 2024
pulisher
Sep 09, 2024

IMVT Stock Up on Upbeat Data From Graves' Disease Study of Batoclimab - Benzinga

Sep 09, 2024
pulisher
Sep 09, 2024

Illumina court ruling limits EU regulators’ merger review power - MedTech Dive

Sep 09, 2024
pulisher
Sep 09, 2024

A step toward better health outcomes in India - Illumina

Sep 09, 2024
pulisher
Sep 09, 2024

FDA Approves Illumina's TruSight Oncology Comprehensive Assay, Now Offered by PreCheck Health Services as "SolidTumorCheck+" -- A Breakthrough in Precision Oncology - Longview News-Journal

Sep 09, 2024
pulisher
Sep 09, 2024

Certuity LLC Makes New $881,000 Investment in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat

Sep 09, 2024
pulisher
Sep 09, 2024

FDA Approves Illumina Cancer Biomarker Test - San Diego Business Journal

Sep 09, 2024
pulisher
Sep 09, 2024

Allspring Global Investments Holdings LLC Has $88,000 Stock Position in Illumina, Inc. (NASDAQ:ILMN) - Defense World

Sep 09, 2024
pulisher
Sep 09, 2024

Unparalleled Research on Next-Generation Sequencing Analysis - openPR

Sep 09, 2024
pulisher
Sep 09, 2024

Epigenetics Market Projections: Industry Growth and Size - openPR

Sep 09, 2024
pulisher
Sep 08, 2024

New Mexico Educational Retirement Board Acquires 24,350 Shares of Illumina, Inc. (NASDAQ:ILMN) - MarketBeat

Sep 08, 2024
pulisher
Sep 08, 2024

Candriam S.C.A. Boosts Stock Position in Illumina, Inc. (NASDAQ:ILMN) - Defense World

Sep 08, 2024
pulisher
Sep 07, 2024

Weil Company Inc. Sells 5,266 Shares of Illumina, Inc. (NASDAQ:ILMN) - MarketBeat

Sep 07, 2024
pulisher
Sep 06, 2024

EU Antitrust Chief Charts Path Forward After Illumina Setback - Law360

Sep 06, 2024
pulisher
Sep 06, 2024

Illumina Inc. stock underperforms Friday when compared to competitors - MarketWatch

Sep 06, 2024
pulisher
Sep 06, 2024

Kornitzer Capital Management Inc. KS Sells 4,142 Shares of Illumina, Inc. (NASDAQ:ILMN) - MarketBeat

Sep 06, 2024
pulisher
Sep 06, 2024

Rhumbline Advisers Increases Stock Position in Illumina, Inc. (NASDAQ:ILMN) - Defense World

Sep 06, 2024
pulisher
Sep 06, 2024

Whole Genome Bisulfite Sequencing (WGBS) Market Key Dynamics - openPR

Sep 06, 2024
pulisher
Sep 06, 2024

Illumina wins Grail battle in blow to EU merger power - Yahoo Finance UK

Sep 06, 2024
pulisher
Sep 05, 2024

Illumina Wins Appeal in Europe Over Grail Acquisition, Avoids €432M Fine - Zenopa

Sep 05, 2024
pulisher
Sep 05, 2024

Opinion | Illumina’s Antitrust Vindication - The Wall Street Journal

Sep 05, 2024
pulisher
Sep 05, 2024

Illumina decision: ‘Blow to the Commission’s quick-fix merger rules’ - International Financial Law Review

Sep 05, 2024

Illumina Inc Stock (ILMN) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
diagnostics_research WAT
$325.86
price up icon 1.17%
diagnostics_research LH
$221.13
price up icon 0.49%
$300.00
price up icon 0.10%
diagnostics_research MTD
$1,383.06
price up icon 0.70%
diagnostics_research A
$137.31
price up icon 0.67%
Cap:     |  Volume (24h):